|
Home | Medical-Newswire.Com:
|
 (Medical-NewsWire.com, August 01, 2017 ) Ovarian Cancer - Heat Map and AnalysisOvarian Cancer (OC) is the fifth most common malignancy diagnosed in women, and the most common gynecological cancer, with an estimated 225,000 new cases diagnosed globally in 2008. Rates are particularly high in developed...
Source: EmailWire.com
 (Medical-NewsWire.com, August 01, 2017 ) Rheumatoid Arthritis - Heat Map and AnalysisRheumatoid Arthritis (RA) is a chronic, progressive and currently incurable autoimmune disease that primarily affects the joints. Disease progression results in stiffness and pain, especially in the hands and feet,...
Source: EmailWire.com
 (Medical-NewsWire.com, August 01, 2017 ) Frontier Pharma: Type 2 Diabetes Mellitus - GPCRs and Protein Kinases Dominate Pipeline, with Most Promising First-in-Class Targets Demonstrating Potential Disease-Modifying EffectsType 2 diabetes mellitus (T2DM) is a chronic, progressive and serious metabolic...
Source: EmailWire.com
 (Medical-NewsWire.com, August 01, 2017 ) "Glycoprotein IIb-IIIa (GPIIb/IIIa) Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Glycoprotein IIb-IIIa (GPIIb/IIIa) Inhibitors. The Report covers the product profiles...
Source: EmailWire.com
 (Medical-NewsWire.com, August 01, 2017 ) Publisher's, "Glycogen Synthase Kinase 3 (GSK-3) Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Glycogen Synthase Kinase 3 (GSK-3) Inhibitors. The Publisher's Report...
Source: EmailWire.com
 (Medical-NewsWire.com, August 01, 2017 ) Publisher's, "Glucosylceramide Synthase Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Glucosylceramide Synthase Inhibitors. The Publisher's Report covers the product...
Source: EmailWire.com
 (Medical-NewsWire.com, August 01, 2017 ) Report, "Glioblastoma Multiforme (GBM)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016", provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key...
Source: EmailWire.com
 (Medical-NewsWire.com, August 01, 2017 ) This report studies Shock Absorber in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.This report...
Source: EmailWire.com
 (Medical-NewsWire.com, August 01, 2017 ) Gastrointestinal Stromal Tumors (GIST) -Market Insights, Epidemiology and Market Forecast-2023" Reports provides an overview of the disease and global market trends of the Crohn's disease for the seven major markets ie: United States, EU5 (France, Germany,...
Source: EmailWire.com
 (Medical-NewsWire.com, August 01, 2017 ) " Gastrointestinal Stromal Tumor (GIST)-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Gastrointestinal Stromal Tumor (GIST). The Report covers the product profiles in various...
Source: EmailWire.com
 (Medical-NewsWire.com, August 01, 2017 ) This report studies Prosthetic Foot in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.This report...
Source: EmailWire.com
 (Medical-NewsWire.com, August 01, 2017 ) Publisher's, "GABAB Modulators-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the GABAB Modulators. The Publisher's Report covers the product profiles in various stages of development...
Source: EmailWire.com
 (Medical-NewsWire.com, August 01, 2017 ) Publisher's, "GABA Receptor Agonists-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the GABA Receptor Agonists. The Publisher's Report covers the product profiles in various stages...
Source: EmailWire.com
 (Medical-NewsWire.com, August 01, 2017 ) Publisher's, "G2 Checkpoint Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the G2 Checkpoint Inhibitors. The Publisher's Report covers the product profiles in various stages...
Source: EmailWire.com
 (Medical-NewsWire.com, August 01, 2017 ) This report studies Needles for Medical Purposes in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.This...
Source: EmailWire.com
|
|
|
|
